Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0848-2026

Ivenix Infusion System (IIS), Large Volume Pump. Recall

Ivenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Ivenix Infusion System (IIS), Large Volume Pump.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0848-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Nov 3, 2025
FDA report date
Dec 10, 2025
Quantity in commerce
15,862 units
Distribution
See key details
FDA cause
Labeling design

What is being recalled?

Ivenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.

Affected model & UDI checker

Search the exact identifiers published for Z-0848-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
LVP-0004Ivenix Infusion System (IIS), Large Volume Pump.Check source noticeNot specified
Not specifiedIvenix Infusion System (IIS), Large Volume Pump.Check source notice00811505030320
FDA code information

Model Number: LVP-0004. UDI-DI: 00811505030320.

View the original FDA recall notice

Why was this product recalled?

Downstream Occlusion alarms may occur during procedures using low flow infusion rates when a check valve* is added to the Ivenix Administration Set.

What actions did Fresenius Kabi USA, LLC take?

Fresenius Kabi notified consignees on about 11/03/2025 via emailed letter. Consignees were informed of the issue and instructed to account for additional backpressure if check valve is used when configuring the downstream occlusion pressure alarm setting, adjust the occlusion alarm pressure to allow for a more balanced approach between occlusion detection and avoidance of unnecessary alarms, and continue to follow all Instructions for Use and institutional policies regarding infusion pump setup, monitoring, and alarm response. Consignees were requested to ensure all relevant persons within the organization are informed about this letter and the actions as described per the enclosed Tip Sheet on How to Use a Check Valve with the Ivenix Pump & Administration Sets. Additionally, consignees were requested complete and return the Customer Reply Form. Fresenius Kabi plans to update the Instructions for Use to include the information presented in the "Required Actions for Users", "Important Note on Check Valve Usage" and/or Tip Sheet on "How to Use a Check Valve with the Ivenix Pump & Administration Sets" for which scheduling is still being finalized.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology